Warning: This security is no longer trading.
Aravive Biologics and Versartis Complete Merger
Versartis, Inc. (VSAR): Price and Financial Metrics
VSAR Price/Volume Stats
| Current price | $1.19 | 52-week high | $2.76 |
| Prev. close | $1.21 | 52-week low | $1.14 |
| Day low | $1.18 | Volume | 349,900 |
| Day high | $1.30 | Avg. volume | 479,428 |
| 50-day MA | $1.56 | Dividend yield | N/A |
| 200-day MA | $1.76 | Market Cap | 43.13M |
VSAR Stock Price Chart Interactive Chart >
Versartis, Inc. (VSAR) Company Bio
Versartis is an endocrine-focused biopharmaceutical company initially developing somavaratan (VRS-317), a novel, long-acting form of recombinant human growth hormone for the treatment of growth hormone deficiency (GHD). The company was founded in 2008 and is based in Menlo Park, California.
VSAR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...